Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

Bibliographical data

Original languageEnglish
ISSN1556-0864
DOIs
Publication statusPublished - 12.2018
PubMed 30205165